Tag: Merrimack Pharmaceuticals Inc

  • Recent Insider Buying: Hercules Offshore (NASDAQ:HERO), Opko Health (NYSE:OPK), Prospect Capital Corporation (NASDAQ:PSEC), Merrimack Pharmaceuticals Inc, MACK, NASDAQ:MACK, Republic Services (NYSE:RSG)

    Hercules Offshore (NASDAQ:HERO) CEO John T. Rynd purchased 36,000 shares of Hercules Offshore stock on the open market in a transaction dated Tuesday, June 24th. The shares were purchased at an average price of $4.01 per share, for a total transaction of $144,360.00. Following the acquisition, the chief executive officer now directly owns 1,006,079 shares of the company’s stock, valued at approximately $4,034,377. Hercules Offshore, Inc. (NASDAQ:HERO) net profit margin is -9.00% and weekly performance is -20.73%. On last trading day company shares ended up $3.94. Analysts mean target price for the company is $5.79. Hercules Offshore, Inc. (NASDAQ:HERO) distance from 50-day simple moving average (SMA50) is -12.53%.

    Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 15,000 shares of Opko Health stock on the open market in a transaction dated Monday, June 23rd. The shares were purchased at an average price of $9.05 per share, for a total transaction of $135,750.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,986,875. Opko Health Inc. (NYSE:OPK) shares fell -2.98% in last trading session and ended the day on $8.78. OPK Gross Margin is 43.40% and its return on assets is -10.50%. Opko Health Inc. (NYSE:OPK) quarterly performance is -5.49%.

    Prospect Capital Corp. (NASDAQ:PSEC) CFO Brian H. Oswald acquired 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 12th. The stock was purchased at an average price of $10.25 per share, for a total transaction of $307,500.00. Following the completion of the acquisition, the chief financial officer now directly owns 121,700 shares of the company’s stock, valued at approximately $1,247,425. Prospect Capital Corporation (NASDAQ:PSEC) shares moved down -0.10% in last trading session and was closed at $10.43, while trading in range of $10.41 – $10.50. Prospect Capital Corporation (NASDAQ:PSEC) year to date (YTD) performance is -2.16%.

    Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director Gary L. Crocker purchased 36,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, June 23rd. The shares were purchased at an average cost of $6.84 per share, for a total transaction of $246,240.00. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) ended the last trading day at $7.16. Company weekly volatility is calculated as 5.28% and price to cash ratio as 5.96. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) showed a negative weekly performance of -7.13%.

    Republic Services (NYSE:RSG) major shareholder Cascade Investment Llc bought 183,577 shares of Republic Services stock in a transaction dated Thursday, June 19th. The stock was purchased at an average cost of $37.24 per share, with a total value of $6,836,407.48. Following the completion of the purchase, the insider now directly owns 91,212,512 shares in the company, valued at approximately $3,396,753,947.Republic Services, Inc. (NYSE:RSG) shares moved down -0.11% in last trading session and was closed at $37.36, while trading in range of $37.26 – $37.42. Republic Services, Inc. (NYSE:RSG) year to date (YTD) performance is 13.38%.